The modified PAGE-B (mPAGE-B), developed in 2018, by adding albumin to the original score, has shown improved discrimination for HCC risk prediction across both Asian and non-Asian populations receiving antiviral treatments [75,78,79]. Here, ALB is linked to hepatocellular carcinoma.